Código QR

Clinical outcomes of carbapenem therapy in OXA-48–producing Enterobacterales infections: a French multicentre cohort, systematic review, and meta-analysis

OXA-48–producing Enterobacterales (OXA-48-PE) represent a growing global health threat. Most of OXA-48–PE remain categorized susceptible to carbapenems, which might encourage their use despite uncertain clinical efficacy. This study evaluated clinical outcomes of infections caused by OXA-48-PE treat...

Descripción completa

Guardado en:
Autores principales: Laurent Dortet, Charlotte Moreau, Aurélien Dinh, Rémy A. Bonnin, Lélia Escaut, Manon Seguret, Laura Weber, Samy Figueiredo, Benoît Pilmis
Formato: Artigo
Lenguaje:Inglês
Publicado: Taylor & Francis Group 2026-12-01
Colección:Emerging Microbes and Infections
Materias:
OXA-48
carbapenemase-producing Enterobacterales
carbapenem therapy
ceftazidime-avibactam
antimicrobial resistance
meta-analysis
Acceso en línea:https://www.tandfonline.com/doi/10.1080/22221751.2026.2671518
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares